Sarah Wenzel
Family · Lawrenceville, GANPI 1932770385
Payments from drug & device makers
Across 187 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$537
- AbbVie$502
- Otsuka America Pharmaceutical, Inc.$453
- GSK$391
- Novo Nordisk$230
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$213
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,550100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 28 | $537 |
| AbbVie | 26 | $502 |
| Otsuka America Pharmaceutical, Inc. | 21 | $453 |
| GSK | 18 | $391 |
| Novo Nordisk | 10 | $230 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $213 |
| Lundbeck LLC | 7 | $160 |
| Biohaven Pharmaceutical Holding Company Ltd. | 14 | $146 |
| Pfizer | 8 | $145 |
| Lilly USA, LLC | 6 | $108 |
| Amgen | 6 | $100 |
| Exact Sciences | 5 | $97 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $65 |
| Boehringer Ingelheim | 3 | $63 |
| Idorsia Pharmaceuticals US Inc | 4 | $60 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Corcept Therapeutics | 2 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Dexcom, Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Novartis | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AREXVY$120
How this compares
$3,550 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 119 | $126,217 |
| MounjaroTirzepatide | 46 | $57,727 |
| RybelsusSemaglutide | 34 | $48,003 |
| FarxigaDapagliflozin Propanediol | 46 | $45,692 |
| EliquisApixaban | 23 | $34,800 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $33,396 |
| VraylarCariprazine Hcl | 17 | $23,796 |
| JardianceEmpagliflozin | 14 | $22,436 |
| RexultiBrexpiprazole | 13 | $21,360 |
| TrulicityDulaglutide | 22 | $19,327 |
| Repatha SureclickEvolocumab | 25 | $18,528 |
| LinzessLinaclotide | 22 | $16,779 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $13,597 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 16 | $10,274 |
| JanuviaSitagliptin Phosphate | 11 | $8,325 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $230 | $174,221153 claims |
| Lilly USA, LLCMounjaro, Trulicity | $108 | $77,05468 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $391 | $57,26760 claims |
| AstraZenecaFarxiga | $537 | $45,69246 claims |
| AbbVieVraylar, Linzess | $502 | $40,57539 claims |
| PfizerEliquis | $145 | $34,80023 claims |
| Boehringer IngelheimJardiance | $63 | $22,43614 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $453 | $21,36013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.
Other family in Lawrenceville
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Jennifer BlackLawrenceville$19K
- Ashley BeikmannLawrenceville$16K
- Allie McAllisterMarietta$299K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.